About Us
Science & Technology
Products
Alliances
News
Investors
Careers
Trubion  

News & Events
   Press Releases
   Events & Presentations


Stock Information
TRBN - (NASD)
$6.93   - 0.16 		05-13-08
4:00 PM ET
Delayed at least 20 mins. Data provided by TurboFeed.

 
Print    Email

Press Releases

 = Add to Briefcase
All 2008 Releases
Trubion Pharmaceuticals Inc. Reports First Quarter 2008 Results
05-08-08 		PDF Add to Briefcase
Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis
05-07-08 		PDF Add to Briefcase
Trubion Pharmaceuticals Provides Announcement Dates for First-Quarter Earnings Conference Call
05-01-08 		PDF Add to Briefcase
Trubion Announces Presentations at April/May Investor Conferences
04-24-08 		PDF Add to Briefcase
Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis
04-21-08 		PDF Add to Briefcase
Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
03-27-08 		PDF Add to Briefcase
Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
03-13-08 		PDF Add to Briefcase
Trubion Pharmaceuticals Announces Dates for Fourth-Quarter and Year-End 2007 Earnings Conference Call
03-06-08 		PDF Add to Briefcase
Trubion Announces Presentations at Upcoming Investor Conferences
03-05-08 		PDF Add to Briefcase
Showing 1-9 of 9 releases